Value Bridge — BAPTIST MEDICAL CENTER
Current $16M → Target $55M (+$39.4M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$15.7M
Current EBITDA
$55.1M
Target EBITDA
+$39.4M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$8.9M
Payer Mix Optimization
$21.4M
Cost to Collect Reduction
$7.1M
Clean Claim Improvement
$5.3M
Volume & Rate Growth
$35.6M
What This Means
The 7-lever model projects a 251% EBITDA uplift from $16M to $55M. The highest-impact lever is Volume & Rate Growth at $14.3M probability-weighted.
IC talking point: "We see $39M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $433M in equity value creation."